Recital 2, Regulation (EU) 2024/1381

In forcesince 23 May 2024

Under Article 15 of Regulation (EU) 2021/2282, the Commission is to lay down detailed procedural rules for the implementation of Articles 8 to 14 of that Regulation as regards conducting and updating joint clinical assessments. In particular, under Article 15(1), points (a) and (c), of Regulation (EU) 2021/2282, the Commission is to adopt detailed procedural rules for the cooperation, in particular by exchange of information, with the European Medicines Agency on the preparation and update of joint clinical assessments of medicinal products and for the interaction, including timing thereof, with and between the Coordination Group, its subgroups and the health technology developers, patients, clinical experts and other relevant experts during joint clinical assessments and updates.